참고문헌
- Kuhnel F, Schulte B, Wirth T, Woller N, Schafers S, Zender L, Manns M, Kubicka S: Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 78;13743-13754, 2004 https://doi.org/10.1128/JVI.78.24.13743-13754.2004
- Basak SK, Kiertscher SM, Harui A, Roth MD: Modifying adenoviral vectors for use as gene-based cancer vaccines. Viral Immunol 17;182-196, 2004 https://doi.org/10.1089/0882824041310603
- Rusell WC: Update on adenovirus and its vector. J Gen Virol 81;2573-2604, 2000 https://doi.org/10.1099/0022-1317-81-11-2573
- Barnes MN, Coolidge CJ, Hemminki A, Alvarez RD, Curiel DT: Conditionally replicative adenoviruses for ovarian cancer therapy. Mol Cancer Ther 1;435-439, 2002
- Yoon JS, Jung YT, Hong SK, Kim SH, Shin MC, Lee DG, Shin WS, Min WS, Park SY: Characteristics of HIV-TAT protein transduction domain. J Microbiol 42;328-335, 2004
- Vives E, Brodin P, Lebleu B: A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272;16010-16017, 1997 https://doi.org/10.1074/jbc.272.25.16010
- Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF:Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4;1449-1452, 1998 https://doi.org/10.1038/4042
- Frankel AD, Pabo CO: Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55;1189-1193, 1988 https://doi.org/10.1016/0092-8674(88)90263-2
- Green M, Loewenstein PM: Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55;1179-1188, 1988 https://doi.org/10.1016/0092-8674(88)90262-0
- Schwarze SR, Dowdy SF: In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21;45-48, 2000 https://doi.org/10.1016/S0165-6147(99)01429-7
- Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF: Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 61;474-477, 2001
-
Wang HY, Fu T, Wang G, Zeng G, Perry-Lalley DM, Yang JC, Restifo NP, Hwu P, Wang RF: Induction of
$CD4^+$ T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J Clin Invest 109;1463-1470, 2002 https://doi.org/10.1172/JCI200215399 - Zhang X, Gordon JR, Xiang J: Advances in dendritic cellbased vaccine of cancer. Cancer Biother Radiopharm 17;601-619, 2002 https://doi.org/10.1089/108497802320970217
- Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ:Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 158;3270-3276, 1997
- Wan Y, Emtage P, Foley R, Carter R, Gauldie J: Murine dendritic cells transduced with an adenoviral vector expres sing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression. Int J Oncol 14;771-776, 1999
- Yi SA, Sohn HJ, Kim CH, Park MY, Oh ST, Kim TG:Enhanced CEA-specific immune responses by TAT-LLO Fusion protein. Immune Network 5;172-178, 2005 https://doi.org/10.4110/in.2005.5.3.172
- Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176;1693-1702, 1992 https://doi.org/10.1084/jem.176.6.1693
- Eliot M, Gilardi-Hebenstreit P, Toma B, Perricaudet M: Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J Gen Virol 71;2425-2431, 1990 https://doi.org/10.1099/0022-1317-71-10-2425
- Heiser A, Dahm P, Yancey DR, Maurice MA, Boczkowski D, Nair SK, Gilboa E, Vieweg J: Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 164;5508-5514, 2000 https://doi.org/10.4049/jimmunol.164.10.5508
- Pereboev AV, Nagle JM, Shakhmatov MA, Triozzi PL, Matthews QL, Kawakami Y: Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol Ther 9;712-720, 2004 https://doi.org/10.1016/j.ymthe.2004.02.006
- Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R, Giordano FJ, Sessa WC: Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 9;357-362, 2003 https://doi.org/10.1038/nm835
- Anikeeva N, Lebedeva T, Sumaroka M, Kalams SA, Sykulev Y: Soluble HIV-specific T cell receptor: expression, purification and analysis of the specificity. J Immunol Methods 277:75-86, 2003 https://doi.org/10.1016/S0022-1759(03)00179-0
- Deml L, Wolf H, Wagner R: High-level expression of hepatitis B virus surface antigen in stably transfected Drosophila Schneider-2 cells. J Virol Methods 79:191-203, 1999 https://doi.org/10.1016/S0166-0934(99)00021-X
- Yoon SH, Cho HI, Kim TG: Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro. Exp Mol Med 37;567-574, 2005 https://doi.org/10.1038/emm.2005.70
- Elkord E, Williams PE, Kynaston H, Rowbottom AW: Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 114;204-212, 2005 https://doi.org/10.1111/j.1365-2567.2004.02076.x